GIACOBBE, DANIELE ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 19.761
AS - Asia 1.135
SA - Sud America 175
NA - Nord America 119
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 1
Totale 21.214
Nazione #
IT - Italia 19.715
SG - Singapore 470
VN - Vietnam 293
CN - Cina 277
BR - Brasile 109
US - Stati Uniti d'America 102
AR - Argentina 31
HK - Hong Kong 23
ID - Indonesia 16
BD - Bangladesh 14
EC - Ecuador 12
MX - Messico 11
IQ - Iraq 8
NL - Olanda 8
RU - Federazione Russa 8
ZA - Sudafrica 8
CO - Colombia 6
ES - Italia 6
VE - Venezuela 6
JO - Giordania 5
PY - Paraguay 5
DE - Germania 4
GB - Regno Unito 4
IN - India 4
NP - Nepal 4
AT - Austria 3
CL - Cile 3
ET - Etiopia 3
JP - Giappone 3
MA - Marocco 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
FR - Francia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PK - Pakistan 2
PL - Polonia 2
SE - Svezia 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
BO - Bolivia 1
CA - Canada 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TR - Turchia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 21.214
Città #
Genoa 8.485
Genova 6.926
Vado Ligure 2.159
Rapallo 2.009
Singapore 125
Ho Chi Minh City 115
Beijing 96
Bordighera 78
Hanoi 65
Ashburn 60
Hong Kong 23
Haiphong 16
Milan 14
Biên Hòa 13
Tianjin 12
Da Nang 9
Quito 7
Denver 6
Jakarta 6
Rome 6
Thái Nguyên 6
Amman 5
Curitiba 5
Hải Dương 5
Johannesburg 5
Mexico City 5
Chicago 4
Ninh Bình 4
San Jose 4
Addis Ababa 3
Asunción 3
Baghdad 3
Brasília 3
Buenos Aires 3
Carapicuíba 3
Dhaka 3
Fortaleza 3
Guangzhou 3
Guayaquil 3
Maceió 3
Madrid 3
Phủ Lý 3
Presidencia Roque Sáenz Peña 3
Quảng Ngãi 3
Salvador 3
Tokyo 3
Treviglio 3
Almaty 2
Bishkek 2
Bắc Giang 2
Can Tho 2
Cantù 2
Caracas 2
Catania 2
Duhok 2
Erbil 2
Frankfurt am Main 2
Houston 2
Itaquaquecetuba 2
Lahore 2
Londrina 2
Los Angeles 2
Maracay 2
Mumbai 2
Naples 2
New York 2
Nha Trang 2
Nuremberg 2
Orem 2
Ospitaletto 2
Phúc Yên 2
Poplar 2
Portico di Caserta 2
Quilmes 2
Salt Lake City 2
San Giuliano Terme 2
Santo Domingo 2
Sharjah 2
Stockholm 2
São Paulo 2
Sóc Trăng 2
Thái Bình 2
Tunis 2
Uberlândia 2
Verona 2
Vienna 2
Warsaw 2
Yên Bái 2
Abidjan 1
Aiuaba 1
Alexandria 1
Amsterdam 1
Angra dos Reis 1
Ankara 1
Antananarivo 1
Anápolis 1
Apuí Municipality 1
Apóstoles 1
Arese 1
Atlanta 1
Totale 20.421
Nome #
Artificial intelligence and prescription of antibiotic therapy: present and future 353
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 281
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 263
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 215
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 206
Mould Infections of Traumatic Wounds: A Brief Narrative Review 204
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 198
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 189
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area 187
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 182
Commentary: Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis 170
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 170
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 169
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 167
Use of colistin in adult patients: a cross-sectional study 166
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 165
Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population 165
Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy 163
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 162
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 162
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 160
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response 159
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review 159
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 156
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 155
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 154
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 153
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 149
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 149
Bloodstream infections in critically ill patients with COVID-19 148
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 145
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 144
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor 144
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 143
Will new antimicrobials overcome resistance among Gram-negatives? 142
Management of KPC-producing Klebsiella pneumoniae infections 142
Aortic cross-clamp time and cardiopulmonary bypass time: prognostic implications in patients operated on for infective endocarditis 142
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 140
Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A 8-year retrospective study in a large teaching hospital in northern Italy 138
Respiratory Fungal Diseases in Adult Patients With Cystic Fibrosis 137
Post-operative abdominal infections: epidemiology, operational definitions, and outcomes 136
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals 135
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 133
The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis 132
Treatment of Infections Due to MDR Gram-Negative Bacteria 132
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic 131
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 130
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 130
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 129
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 127
Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo 124
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 124
First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis 123
A look at clinical trial design for new antimicrobials for the adult population 123
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 123
The role of fosfomycin for multidrug-resistant gram-negative infections 123
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 123
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 122
Epidemiology and outcome of Klebsiellapneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review 122
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 122
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after cardiac surgery 121
Impact of negative blood cultures on outcome after surgery for acute infective endocarditis 119
Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19 119
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 117
Bloodstream infections in internal medicine 115
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from multicenter case-control-control-study. 114
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective 113
Isolation of Candida auris from invasive and noninvasive samples of a patient suffering from vascular disease, Italy, July 2019 113
Ceftolozane/tazobactam: place in therapy 112
Risk factors andmortality of healthcare-associated and community-acquired Staphylococcus aureusbacteraemia 111
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients with Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae 110
History of schistosomiasis (bilharziasis) in humans: from Egyptian medical papyri to molecular biology on mummies 110
Culture-negative infective endocarditis (CNIE): impact on postoperative mortality 110
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 108
Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment 105
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 105
Factors associated with lack of viral suppression at delivery 104
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 104
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 103
null 102
Ceftobiprole: drug evaluation and place in therapy 102
New insights into infections due to multidrug resistant gram negative bacteria: The interplay between lab and clinic 98
Efficacy and Safety of Meropenem–Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis 96
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 96
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 95
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia 94
Risk factors for candidemia after open-heart surgery: results from a multicenter case-control study 94
A wide database for future studies aimed at improving early recognition of candidemia 94
A NLP Pipeline for the Automatic Extraction of a Complete Microorganism’s Picture from Microbiological Notes 93
Valutazione dei fattori di rischio per lo sviluppo di candidemia dopo interventi di cardiochirurgia maggiore 92
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 92
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 91
Pitfalls of defining combination therapy for carbapenem-resistant Enterobacteriaceae in observational studies 90
EReply. Diagnostic intricacies and fortuitous treatment approaches for carbapenem-resistant Klebsiella pneumoniae 89
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study 89
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 88
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series 88
Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients 87
Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter Study 87
Colistin versus colistin plus meropenem for severe infections 86
Totale 13.496
Categoria #
all - tutte 91.916
article - articoli 89.354
book - libri 0
conference - conferenze 1.146
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.130
Totale 183.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.114 0 0 0 0 0 99 113 189 160 220 165 168
2021/20221.858 72 52 93 182 87 134 68 357 223 194 108 288
2022/20232.468 222 207 31 232 294 324 85 161 400 145 303 64
2023/20241.690 80 187 45 216 150 252 142 112 83 77 127 219
2024/20255.696 152 358 157 386 784 580 548 928 240 284 546 733
2025/20264.688 1.262 458 914 727 1.161 166 0 0 0 0 0 0
Totale 21.884